Porcilis AR-T DF
Country: Unjoni Ewropea
Lingwa: Ingliż
Sors: EMA (European Medicines Agency)
Fuljett ta 'informazzjoni
(PIL)
05-05-2014
Karatteristiċi tal-prodott
(SPC)
05-05-2014
Rapport ta 'Valutazzjoni Pubblika
(PAR)
20-12-2011
Ingredjent attiv:
protein dO (non-toxic deletion derivative of Pasteurella multocida dermonecrotic toxin), inactivated Bordetella bronchiseptica cells
Disponibbli minn:
Intervet International BV
Kodiċi ATC:
QI09AB04
INN (Isem Internazzjonali):
adjuvanted vaccine against progressive atrophic rhinitis in piglets
Grupp terapewtiku:
Pigs (gilts and sows)
Żona terapewtika:
Immunologicals for suidae
Indikazzjonijiet terapewtiċi:
For the reduction of clinical signs of progressive atrophic rhinitis in piglets by passive oral immunisation with colostrum from dams actively immunised with the vaccine.
Sommarju tal-prodott:
Revision: 6
L-istatus ta 'awtorizzazzjoni:
Authorised
Data ta 'l-awtorizzazzjoni:
2000-11-16
Fuljett ta 'informazzjoni
B. PACKAGE LEAFLET
15
PACKAGE LEAFLET
PORCILIS AR-T DF SUSPENSION FOR INJECTION FOR PIGS
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder and manufacturer:
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis AR-T DF suspension for injection for pigs
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Each dose of 2 ml contains:
Active substances:
- Protein dO (non-toxic deletion derivative of
_Pasteurella _
_multocida _
dermonecrotic toxin)
≥
6.2 log2 TN titre
1
- Inactivated
_Bordetella bronchiseptica_
cells.
≥
5.5 log2 Aggl. titre
2
1
Mean toxin neutralising titre obtained after repeated vaccination of a
half dose in rabbits.
2
Mean agglutination titre obtained after a single vaccination of a half
dose in rabbits
Adjuvant:
dl-α-tocopherol acetate
150 mg
Excipient:
Formaldehyde
≤1 mg
4.
INDICATION(S)
For the reduction of clinical signs of progressive atrophic rhinitis
in piglets by passive oral
immunisation with colostrum from dams actively immunised with the
vaccine.
5.
CONTRAINDICATIONS
None.
6.
ADVERSE REACTIONS
A mean transient increase in body temperature of 1.5°C, in some pigs
up to 3 °C, which could lead to an
abortion, can generally be measured on the day of vaccination or the
following day. Reduced activity and
lack of appetite on the day of vaccination very commonly occurs and/or
a transient swelling (max
16
diameter: 10 cm) for up to two weeks may arise at the site of
injection. In very rare cases other immediate
hypersensitivity reactions, e.g. vomiting, dyspnoea and shock, may
occur.
If you notice any serious effects or other effects not mentioned in
this package leaflet, please inform
your veterinary surgeon.
7.
TARGET SPECIES
Pigs (sows and gilts).
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
Administer one dose of 2 ml by intramuscular injectio
Aqra d-dokument sħiħ
Karatteristiċi tal-prodott
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis AR-T DF suspension for injection for pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of 2 ml contains:
ACTIVE SUBSTANCES:
- Protein dO (non-toxic deletion derivative of
_Pasteurella _
_multocida _
dermonecrotic toxin)
≥
6.2 log2 TN titre
1
- Inactivated
_Bordetella bronchiseptica_
cells
≥
5.5 log2 Aggl. titre
2
1
Mean toxin neutralising titre obtained after repeated vaccination of a
half dose in rabbits.
2
Mean agglutination titre obtained after a single vaccination of a half
dose in rabbits
ADJUVANT:
dl-α-tocopherol acetate
150 mg
EXCIPIENT:
Formaldehyde
≤1 mg
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs (sows and gilts).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the reduction of clinical signs of progressive atrophic rhinitis
in piglets by passive oral immunisation
with colostrum from dams actively immunised with the vaccine.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Vaccinate only healthy animals
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
MEDICINAL PRODUCT TO ANIMALS
In case of accidental self-injection, seek medical advice immediately
and show the package leaflet or the
2
label to the physician.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
A mean transient increase in body temperature of 1.5 °C, in some pigs
up to 3 °C, which could lead to an
abortion, can generally be measured on the day of vaccination or the
following day. Reduced activity and
lack of appetite on the day of vaccination very commonly occurs and/or
a transient swelling (max
diameter: 10 cm) for up to two weeks may arise at the site of
injection. In very rare cases other immediate
hypersensitivity reactions, e.g. vomiting, dyspnoea and shock, may
occur.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Can be use
Aqra d-dokument sħiħ
